These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 28161220)
1. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin. Kuroski JE; Young S Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220 [TBL] [Abstract][Full Text] [Related]
2. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa. Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845 [TBL] [Abstract][Full Text] [Related]
3. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants? Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851 [TBL] [Abstract][Full Text] [Related]
4. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation. Sin JH; Berger K; Lesch CA J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767 [TBL] [Abstract][Full Text] [Related]
5. Emergent reversal of vitamin K antagonists: addressing all the factors. Martin DT; Barton CA; Dodgion C; Schreiber M Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center. Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal. Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage. Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286 [TBL] [Abstract][Full Text] [Related]
10. Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department. Maguire M; Fuh L; Goldstein JN; Marshall AL; Levine M; Howell ML; Parry BA; Rosovsky R; Hayes BD West J Emerg Med; 2019 Jul; 20(4):619-625. PubMed ID: 31316701 [TBL] [Abstract][Full Text] [Related]
11. Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding. Holt T; Taylor S; Abraham P; Mcmillian W; Harris S; Curtis J; Elder T Int J Crit Illn Inj Sci; 2018; 8(1):36-40. PubMed ID: 29619338 [TBL] [Abstract][Full Text] [Related]
12. A new kid on the block: Outcomes with Kcentra 1 year after approval. Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal. Bajdas H; Handzel M; Uttaro E; Jones CMC; Kokanovich K; Acquisto NM Thromb Res; 2022 Jun; 214():76-81. PubMed ID: 35512560 [TBL] [Abstract][Full Text] [Related]
14. The outcomes of three-factor prothrombin complex concentrate (3F-PCC) in warfarin anticoagulation reversal: a prospective, single-arm, open-label, multicentre study. Koh HP; Jagan N; George D; Mazlan-Kepli W; Mohamed S; Lim HT; Ross NT; Mazlan AM J Thromb Thrombolysis; 2021 Oct; 52(3):836-847. PubMed ID: 33748900 [TBL] [Abstract][Full Text] [Related]
15. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011 [TBL] [Abstract][Full Text] [Related]
17. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices. Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470 [TBL] [Abstract][Full Text] [Related]
18. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341 [TBL] [Abstract][Full Text] [Related]
19. Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals. Santibanez M; Lesch CA; Lin L; Berger K J Crit Care; 2018 Dec; 48():183-190. PubMed ID: 30218958 [TBL] [Abstract][Full Text] [Related]